Decline in locomotor functions over time in HIV-infected patients

AIDS

Volumn 28, Issue 10, 2014, Pages 1441-1449

  Richert, Laura ^a,b,c   Brault, Mathilde ^b,c   Mercié, Patrick ^a,b,c   Dauchy, Frédéric Antoine ^b,c   Bruyand, Mathias ^a,c   Greib, Carine ^c   Dabis, François ^a,b,c   Bonnet, Fabrice ^a,b,c   Chêne, Geneviève ^a,b,c   Dehail, Patrick ^b,c,d  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSERM U657   (France)

Author keywords

Five times sit to stand test; Functional impairment; HIV infection; Locomotor performance; Muscle; Physical function

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LOCOMOTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; SITTING; STANDING; TIME; VIRUS LOAD; WALKING SPEED; COMPLICATION; GAIT DISORDERS, NEUROLOGIC; MIDDLE AGED;

ADULT; FEMALE; GAIT DISORDERS, NEUROLOGIC; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84902289670     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000246     Document Type: Article

References (40)

1. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332:556-561.
2. Tiedemann A, Shimada H, Sherrington C, Murray S, Lord S. The comparative ability of eight functional mobility tests for predicting falls in community-dwelling older people. Age Ageing 2008; 37:430-435.
3. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381:752-762.
4. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372:293-299.
5. Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, et al. All-cause mortality in treated HIV-infected adults with CD4 >/U500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012; 41:433-445.
6. Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis 2011; 53:1127-1129.
7. Richert L, Dehail P, Mercie P, Dauchy FA, Bruyand M, Greib C, et al. High frequency of poor locomotor performance in HIVinfected patients. AIDS 2011; 25:797-805.
8. Buehring B, Kirchner E, Sun Z, Calabrese L. The frequency of low muscle mass and its overlap with low bone mineral density and lipodystrophy in individuals with HIV-a pilot study using DXA total body composition analysis. J Clin Densitom 2012; 15:224-232.
9. Erlandson KM, Allshouse AA, Jankowski CM, MaWhinney S, Kohrt WM, Campbell TB. Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr 2013; 63:209-215.
10. Erlandson KM, Allshouse AA, Jankowski CM, Duong S, MaWhinney S, Kohrt WM, et al. Risk factors for falls in HIVinfected persons. J Acquir Immune Defic Syndr 2012; 61:484-489.
11. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011; 66:1030-1038.
12. Oursler KK, Goulet JL, Crystal S, Justice AC, Crothers K, Butt AA, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS 2011; 25:13-20.
13. Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One 2013; 8:e54910.
14. Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, Bacchetti P, et al. Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection. AIDS 2011; 25:1405-1414.
15. Lord SR, Murray SM, Chapman K, Munro B, Tiedemann A. Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people. J Gerontol A Biol Sci Med Sci 2002; 57:M539-543.
16. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 2002; 166:111-117.
17. Thiebaut R, Walker S. When it is better to estimate a slope with only one point. QJM 2008; 101:821-824.
18. Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009; 39:495-501.
19. Bohannon RW, Shove ME, Barreca SR, Masters LM, Sigouin CS. Five-repetition sit-to-stand test performance by communitydwelling adults: a preliminary investigation of times, determinants, and relationship with self-reported physical performance. Isokinet Exerc Sci 2007; 15:77-81.
20. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158:1384-1387.
21. Onder G, Penninx BW, Lapuerta P, Fried LP, Ostir GV, Guralnik JM, et al. Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 2002; 57:M289-293.
22. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Crosssectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000; 55:M709-715.
23. Zhang F, Ferrucci L, Culham E, Metter EJ, Guralnik J, Deshpande N. Performance on five times sit-to-stand task as a predictor of subsequent falls and disability in older persons. J Aging Health 2013; 25:478-492.
24. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or U60 y. Am J Clin Nutr 2004; 80:752-758.
25. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009; 64:1183-1189.
26. Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, Palmer BE, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013; 208:249-259.
27. Visser M. Obesity, sarcopenia and their functional consequences in old age. Proc Nutr Soc 2011; 70:114-118.
28. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L. A comparison of leg power and leg strength within the InCHIANTI study: which influences mobility more J Gerontol A Biol Sci Med Sci 2003; 58:728-733.
29. Dehail P, Bestaven E, Muller F, Mallet A, Robert B, Bourdel- Marchasson I, et al. Kinematic and electromyographic analysis of rising from a chair during a Sit-to-Walk task in elderly subjects: role of strength. Clin Biomech 2007; 22:1096-1103.
30. Puthoff ML, Nielsen DH. Relationships among impairments in lower-extremity strength and power, functional limitations, and disability in older adults. Phys Ther 2007; 87:1334-1347.
31. Russ DW, Scott WB, Oursler KK, King JS. Paradoxical contractile properties in the knee extensors of HIV-infected men treated with antiretroviral therapy. Appl Physiol Nutr Metab 2010; 35:713-717.
32. Kusko RL, Banerjee C, Long KK, Darcy A, Otis J, Sebastiani P, et al. Premature expression of a muscle fibrosis axis in chronic HIV infection. Skelet Muscle 2012; 2:10.
33. Dorfman D. Editorial commentary on high frequency of poor locomotor performance in HIV-infected patients. AIDS 2011; 25:1227.
34. Yahiaoui A, McGough EL, Voss JG. Development of evidencebased exercise recommendations for older HIV-infected patients. J Assoc Nurses AIDS Care 2012; 23:204-219.
35. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165:1179-1184.
36. Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS 2012; 26:303-314.
37. Dufouil C, Richert L, Bruyand M, Amieva H, Dauchy FA, Greib C, et al. Type 2 diabetes is associated with lower cognitive performances in a cohort of HIV-infected patients. ANRS CO3 Aquitaine Cohort, Bordeaux, France, 2007-2009. XIX International AIDS Conference. Washington, DC; 2012. Abstract no. THAB0203.
38. Nakamoto BK, Valcour VG, Kallianpur K, Liang CY, McMurtray A, Chow D, et al. Impact of cerebrovascular disease on cognitive function in HIV-infected patients. J Acquir Immune Defic Syndr 2011; 57:e66-e68.
39. Medapalli RK, Parikh CR, Gordon K, Brown ST, Butt AA, Gibert CL, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr 2012; 60:393-399.
40. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735.